Отчет об анализе размера, доли и тенденций мирового рынка дефибрилляторов – обзор отрасли и прогноз до 2031 года

Анализ мирового рынка дефибрилляторов

Рынок дефибрилляторов, как ожидается, быстро вырастет в течение прогнозируемого периода из-за растущей распространенности сердечно-сосудистых заболеваний. По данным Всемирной организации здравоохранения, сердечно-сосудистые заболевания были основной причиной смертности в 2017 году, на их долю пришлось около 17,9 миллионов смертей во всем мире. Это привело к появлению дефибрилляторов на этом рынке. Метод дефибрилляции подразумевает подачу электрического разряда в сердце, который деполяризует сердечные мышцы и восстанавливает нормальный электрический импульс сердца. Внешние дефибрилляторы — это медицинские устройства для спасения жизни, которые используют пластины или электродные накладки для подачи дефибрилляционных разрядов с целью выявления и восстановления опасных для жизни нерегулярных сердечных ритмов в случае внезапной остановки сердца.  

Размер мирового рынка дефибрилляторов

Объем мирового рынка дефибрилляторов в 2023 году оценивался в 12,88 млрд долларов США, а к 2031 году, по прогнозам, он достигнет 21,02 млрд долларов США, при этом среднегодовой темп роста составит 6,31% в прогнозируемый период с 2024 по 2031 год.

Область отчета и сегментация рынка       

Defibrillators Market Definition

In life-threatening diseases including ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia, a defibrillator is a medical device that administers a therapeutic shock to the patient's heart. It works by sending electric pulses or shockwaves to the heart to help restore a regular heartbeat. Automated external defibrillators (AEDs), manual/wearable external defibrillators, implantable cardioverter defibrillators (ICDs), and transvenous or subcutaneous implantable cardioverter defibrillators are some of the most prevalent types of defibrillators.

Defibrillators Market Dynamics

Drivers

• Increasing prevalence of cardiovascular diseases

The increase in the prevalence of cardiovascular diseases will cushion the growth rate of defibrillators market. Cardiovascular disease (CVD) is the world's leading cause of mortality and disability. Lifestyle diseases including hypertension, obesity, dyslipidemia, and diabetes, are substantial risk factors for CVD, are also on the rise. High blood pressure levels have a significant linear link with the likelihood of developing CVDs.

• Rising adoption of ICDs across healthcare centers

The global defibrillators market is being driven by the rising adoption of ICDs across healthcare centers. Modern ICDs are equipped with cutting-edge subcutaneous and transvenous patches that enhance the patient's overall efficiency and comfort.

Furthermore, the rising focus on providing public-access defibrillators will be a major factor influencing the growth of the defibrillators market. Along with this, increasing urbanization and rising geriatric population are the driving factors accelerating the growth of the defibrillators market. Also, the rise in the changing lifestyle and increasing expenditure on healthcare infrastructure are the major market drivers that will further escalate the growth of defibrillators' growth. Another significant factor that will cushion the defibrillators market's growth rate is the growing focus of manufacturers on the adoption of advanced technologies.

Opportunities

• Growing number of R&D activities

Moreover, the rising number of research and development activities will provide beneficial opportunities for the defibrillators market growth.

Moreover, rise in the number of training and awareness programs on defibrillators and increasing number of emerging markets will further provide beneficial opportunities for the defibrillators market growth during the forecast period.

Restraints/Challenges

• Issues associated with the utilization of implantable and automated external defibrillators

However, issues associated with the utilization of implantable and automated external defibrillators will impede the defibrillators market's growth rate. In the defibrillator market, cybersecurity is a big risk. The current generation of implantable defibrillators has sophisticated technology that allows for remote data transfer. The FDA has expressed worry about these devices being hacked.

• Frequent product recalls

A number of product recalls have occurred in recent years, primarily owing to electrical failure, connector compatibility concerns, and issues relating to specific defibrillators. The market for defibrillators is challenged by frequent product recalls.

On the other hand, the dearth of skilled professionals in under-developed nations will challenge the defibrillators market. Additionally, emergence of unfavorable conditions due to COVID-19 outbreak and lack of awareness about sudden cardiac arrest in developing nations will act as restrain and further impede the growth rate of market during the forecast period of 2024-2031.

This defibrillators market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the defibrillators market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Defibrillators Market

In 2020, the COVID-19 pandemic had a negative impact on the economy and posed numerous obstacles to clinical healthcare practitioners and patients all across the world. Logistical concerns, illness management, prioritizing patients with comorbidities and pre-existing disorders, and further protecting the public and hospital frontline staff from COVID-19 were the key challenges that healthcare systems around the world dealt with. The pandemic has also harmed hospitals' purchasing power, particularly small-scale institutions, which has cancelled or postponed supply transactions, reducing total revenue for all major competitors in the defibrillator industry. Furthermore, many people lost their employment and livelihoods as a result of the lockdowns, which had a significant impact on patient purchasing patterns. COVID-19 had an impact on numerous levels of the value chain, owing to the stringent lockdowns imposed by most governments. Due to newer packaging regulations and country-imposed lockout procedures, the turnaround time for products and services was also impacted. All of these problems have a negative impact on the defibrillator market's manufacturing and supply chain.

Defibrillators Market Scope

The defibrillators market is segmented on the basis of product, end-user and patient type. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Implantable Cardioverter Defibrillators
• External Defibrillators

Based on product, the global defibrillators market has been segmented into implantable cardioverter defibrillators and external defibrillators. Implantable cardioverter defibrillators segment is sub-segmented into transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators. Transvenous implantable cardioverter defibrillators segment is further bifurcated into biventricular ICDS/cardiac resynchronization therapy defibrillators, dual-chamber ICDS and single-chamber ICDs. External defibrillators segment is sub-segmented into automated external defibrillators, manual external defibrillators and wearable cardioverter defibrillators. Automated external defibrillators segment is further bifurcated into semi-automated external defibrillators and fully automated external defibrillators.

End User

• Hospitals
• Clinics, and Cardiac Centres
• Pre-Hospital Care Settings
• Public Access Markets
• Home Care Settings
• Alternate Care Facilities

Based on the end user, the defibrillators market is segmented into hospitals, clinics, cardiac centres, pre-hospital care settings, public access markets, home care settings, and alternate care facilities.

Patient Type

• Adult
• Pediatric

The defibrillators market is also segmented on the basis of patient type into adult, and paediatric.

Defibrillators Market Regional Analysis

The defibrillators market is analyzed and market size insights and trends are provided by country, product, end-user and patient type as referenced above.

The countries covered in the defibrillators market report U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the defibrillators market because of the prevailing sophisticated level of healthcare facilities and rising expenditure for research and development activities in this region. Additionally, rising number of cases of cardiac diseases will flourish the market's growth rate in this region. 

Asia-Pacific is expected to grow during the forecast period due to the rising patient pool and surging awareness about public-access defibrillators in this region. Along with this, rising expenditure on healthcare infrastructure and increasing penetration of defibrillators will propel the market's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The defibrillators market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for defibrillators market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the defibrillators market. The data is available for historic period 2010-2020.

Defibrillators Market Share Analysis

Конкурентная среда рынка дефибрилляторов содержит подробную информацию по конкурентам. Включены следующие сведения: обзор компании, финансовые показатели компании, полученный доход, рыночный потенциал, инвестиции в исследования и разработки, новые рыночные инициативы, глобальное присутствие, производственные площадки и объекты, производственные мощности, сильные и слабые стороны компании, запуск продукта, широта и широта продукта, доминирование в применении. Приведенные выше данные касаются только фокуса компаний на рынке дефибрилляторов.

Лидерами рынка дефибрилляторов, работающими на рынке, являются:

• Medtronic (Ирландия)
• Бостонская научная корпорация (США)
• Конинклийке Philips NV (Нидерланды)
• Страйкер (США)
• NIHON KOKEN KOGYO CO.,LTD. (Токио)
• ZOLL Medical Corporation (США)
• BIOTRONIK SE & Co KG (Германия)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Китай)
• Physio-Control, Inc. (США)
• LivaNova PLC (Великобритания)
• Корпорация Асахи Касей (Япония)
• ШИЛЛЕР (Швейцария)
• MEDIANA Co., Ltd. (Корея)
• Metrax GmbH (Германия)
• Эбботт (США)
• ФУКУДА ДЭНСИ (Япония)
• Progetti srl (Италия)
• HeartSine Technologies LLC. (Вашингтон)
• Defibtech LLC (США)

SKU-1638